Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+56.7Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+20Malignant Bladder Neoplasm+13.3Malignant Vaginal Neoplasm+10Malignant Vulvar Neoplasm+10Malignant Ovarian Neoplasm+6.7Malignant Pancreatic Neoplasm+6.7Malignant Esophageal Neoplasm+3.4Malignant Salivary Gland Neop…+3.3Malignant Mesothelioma+3.3Malignant Prostate Neoplasm+3.3Malignant Kidney Neoplasm0Malignant Lung Neoplasm0Malignant Rectal Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+56.7100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
48292
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
96.7
activityPercentile
40

ranking row 2592769

2=Cutaneous Melanoma+2096.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7542
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2592770

3=Malignant Laryngeal Neoplasm+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3797
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
20

ranking row 2592771

4=Malignant Bladder Neoplasm+13.390Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12225
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
60
activityPercentile
46.7

ranking row 2592772

5=Malignant Vaginal Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
382
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
10
activityPercentile
0

ranking row 2592773

5=Malignant Vulvar Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
765
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2592774

7=Malignant Ovarian Neoplasm+6.780Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14414
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
76.7
activityPercentile
70

ranking row 2592776

7=Malignant Pancreatic Neoplasm+6.780Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
29802
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
86.7
activityPercentile
80

ranking row 2592775

9=Malignant Esophageal Neoplasm+3.473.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12529
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2592777

10=Malignant Salivary Gland Neoplasm+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
685
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2592778

11=Malignant Mesothelioma+3.366.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2371
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2592779

11=Malignant Prostate Neoplasm+3.366.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
30719
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
90
activityPercentile
86.7

ranking row 2592780

13=Malignant Kidney Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12078
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
56.7
activityPercentile
56.7

ranking row 2592782

13=Malignant Lung Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
155969
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2592781

13=Malignant Rectal Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8516
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2592783

16=Malignant Thyroid Gland Neoplasm-3.350Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1354
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2592784

17=Malignant Hypopharyngeal Neoplasm-3.346.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
348
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
6.7
activityPercentile
10

ranking row 2592785

18=Malignant Testicular Neoplasm-3.443.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
335
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
3.3
activityPercentile
6.7

ranking row 2592786

19=Malignant Breast Neoplasm-3.440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41809
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2592787

19=Malignant Gastric Neoplasm-3.440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12319
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
63.3
activityPercentile
66.7

ranking row 2592788

21=Malignant Penile Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
205
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2592789

22=Malignant Central Nervous System Neoplasm-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12609
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
70
activityPercentile
76.7

ranking row 2592790

23=Leukemia-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21532
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
90

ranking row 2592791

23=Malignant Anal Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
511
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
13.3
activityPercentile
23.3

ranking row 2592794

23=Malignant Liver Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13351
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
73.3
activityPercentile
83.3

ranking row 2592793

23=Non-Hodgkin Lymphoma-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
22305
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
83.3
activityPercentile
93.3

ranking row 2592792

27=Hodgkin Lymphoma-1013.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1323
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
26.7
activityPercentile
36.7

ranking row 2592795

28=Malignant Uterine Corpus Neoplasm-16.610Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3185
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
36.7
activityPercentile
53.3

ranking row 2592796

29=Malignant Cervical Neoplasm-16.76.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4092
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
43.3
activityPercentile
60

ranking row 2592797

30=Multiple Myeloma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10714
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
53.3
activityPercentile
73.3

ranking row 2592798

31=Malignant Nasopharyngeal Neoplasm-26.60Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
621
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
16.7
activityPercentile
43.3

ranking row 2592799

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 5eea9c755f62d40bde4e4f3a